Correlation between HBx and VEGF expressions and angiogenesis and metastasis in HBV related hepatocellular carcinoma tissue

Journal of Jilin University Medicine Edition

Volumn 36, Issue 2, 2010, Pages 372-376

  Liu, Kai Ge ^a   Gao, Hong Yan ^a   Zhao, Hui ^a   Niu, Chun Yan ^a   Li, Li ^a  

^a XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus X protein; Liver neoplasms; Microvascular density; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIGEN; HEPATITIS B VIRUS X PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; METASTASIS; PORTAL VEIN; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

EID: 77950935297     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Moon EJ, Jeong CH, Jeong JW, et al. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1&-alpha [J]. FASEB J, 2004, 18 (2): 382-384.
2. Bamberger AM, Riethodorf L, Milde-Langosch K, et al. Strongly reduced expression of the cell cycle inhibitor p27 in endormetrial neoplasia [J]. Virchows Arch, 1999, 434 (5): 423-428. (Pubitemid 29261530)
3. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma [J]: Nat Cancer Inst, 1992, 84 (24): 1875-1887. (Pubitemid 23004615)
4. Casanovas O, Hicklin D, Berger H, et al. Drug resistance by evasion of anti-angiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors [J]. Cancer Cell, 2005, 8 (4): 229-309. (Pubitemid 41443415)
5. Aghi M, Kenneth SC, Rachael J, et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influence their differentiated phenotypes [J]. Cancer Res, 2006, 66 (18): 9054-9064. (Pubitemid 44521124)
6. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer [J]. Oncology, 2005, 69 (suppl 3): 4-10. (Pubitemid 41680947)
7. Weidner N. The importance of tumor angiogenesis: the evidence continues to growth [J]. Am J Clin Pathol, 2004, 122 (5): 675-677. (Pubitemid 39434747)
8. Yoo YG, Cho S, Park S, etal. The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1alpha [J]. FEBS Lett, 2004, 577 (1/2): 121-126.
9. Moon HE, Cheon H, Chun KH, et al. Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha [J]. Oncol Rep, 2006, 16 (4): 929-935.
10. Kim SH, Jeong JW, Park JA, et al. Regulation of the HIF-1alpha stability by histone deacetylases [J]. Oncol Rep, 2007, 17 (3): 647-651.
11. Tong Q, Zheng L, Li B, et al. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells [J]. Exp Cell Res, 2006, 312 (18): 3559-3569. (Pubitemid 44488590)
12. Paloma SC, Samuel MV, Enrique LP, et al. Hepatitis B virus promotes angiopoietin-2 expression in liver tissue [J]. Am J Pathol, 2006, 169 (4): 1215-1222.
13. Xie H, Song J, Liu K, et al. The expression of hypoxia-inducible factor-1 alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein [J]. Dig Dis Sci, 2008, 53 (12): 3225-3233.